Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Circular RNAs in chemotherapy resistance of lung cancer and their potential therapeutic application

Circular RNAs in chemotherapy resistance of lung cancer and their potential therapeutic application Lung cancer is one of the high malignancy‐related incidence and mortality worldwide, accounting for about 13% of total cancer diagnoses. Currently, the use of anti‐cancer agents is still the main therapeutic method for lung cancer. However, cancer cells will gradually show resistance to these drugs with the progress of treatment. And the molecular mechanisms underlying chemotherapy agents resistance remain unclear. circRNAs are newly identified noncoding RNAs molecules with covalently closed circular structures. Previous studies have shown that circRNAs are associated with tumorigenesis and progression of various cancers, including lung cancer. Recently, growing reports have suggested that circRNAs could contribute to drug resistance of lung cancer cell through different mechanisms. Therefore, in this review, we summarized the functions and underlying mechanisms of circRNAs in regulating chemoresistance of lung cancer and discussed their potential applications for diagnosis, prognosis, and treatment of lung cancer. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png IUBMB Life Wiley

Circular RNAs in chemotherapy resistance of lung cancer and their potential therapeutic application

IUBMB Life , Volume 75 (3) – Mar 1, 2023

Loading next page...
 
/lp/wiley/circular-rnas-in-chemotherapy-resistance-of-lung-cancer-and-their-DLJnotZy0x

References (113)

Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2023 International Union of Biochemistry and Molecular Biology
ISSN
1521-6543
eISSN
1521-6551
DOI
10.1002/iub.2624
Publisher site
See Article on Publisher Site

Abstract

Lung cancer is one of the high malignancy‐related incidence and mortality worldwide, accounting for about 13% of total cancer diagnoses. Currently, the use of anti‐cancer agents is still the main therapeutic method for lung cancer. However, cancer cells will gradually show resistance to these drugs with the progress of treatment. And the molecular mechanisms underlying chemotherapy agents resistance remain unclear. circRNAs are newly identified noncoding RNAs molecules with covalently closed circular structures. Previous studies have shown that circRNAs are associated with tumorigenesis and progression of various cancers, including lung cancer. Recently, growing reports have suggested that circRNAs could contribute to drug resistance of lung cancer cell through different mechanisms. Therefore, in this review, we summarized the functions and underlying mechanisms of circRNAs in regulating chemoresistance of lung cancer and discussed their potential applications for diagnosis, prognosis, and treatment of lung cancer.

Journal

IUBMB LifeWiley

Published: Mar 1, 2023

Keywords: chemotherapy; circRNAs; drug resistance; lung cancer; NSCLC

There are no references for this article.